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Neuropeptide FF and FMRFamide Potentiate
Acid-Evoked Currents from Sensory Neurons
and Proton-Gated DEG/ENaC Channels
FF is injected intracerebroventricularly, it elicits hyperal-
gesia and a reduction in morphine-induced analgesia
(Tang et al., 1984; Yang et al., 1985; Kavaliers, 1987;
Raffa, 1988; Brussaard et al., 1989; Roumy and Zajac,
1998). In addition, FMRFamide-like immunoreactive ma-
Candice C. Askwith,* Chun Cheng,² Mutsuhiro Ikuma,*
Christopher Benson,² Margaret P. Price,²
and Michael J. Welsh*²³§
*Howard Hughes Medical Institute
²Department of Internal Medicine
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phine administration, and anti-FMRFamide antibodiesUniversity of Iowa College of Medicine
can enhance morphine's effects (Tang et al., 1984; De-Iowa City, Iowa 52242
villers et al., 1995). However, when administered intra-
thecally, these peptides can have an analgesic effect
thought to be mediated through opioid receptors (Raffa,Summary
1988; Raffa and Connelly, 1992; GouardeÂ res et al., 1993;
Roumy and Zajac, 1998).Acidosis is associated with inflammation and ischemia
Some effects of FMRFamide and neuropeptide FFand activates cation channels in sensory neurons. In-
appear to be mediated through opioid receptors; theseflammation also induces expression of FMRFamide-
effects are blocked by the opioid antagonist naloxonelike neuropeptides, which modulate pain. We found
(Kavaliers and Hirst, 1985; Kavaliers, 1987; Raffa, 1988;that neuropeptide FF (Phe-Leu-Phe-Gln-Pro-Gln-Arg-
GouardeÂ res et al., 1993; Roumy and Zajac, 1998). Yet,Phe amide) and FMRFamide (Phe-Met-Arg-Phe amide)
other effects of FMRFamide and FMRFamide-relatedgenerated no current on their own but potentiated
peptides are independent of opioid receptors and areH1-gated currents from cultured sensory neurons and
insensitive to naloxone (Gayton, 1982; Raffa et al., 1986;heterologously expressed ASIC and DRASIC channels.
Kavaliers, 1987; Raffa, 1988; Allard et al., 1989; RoumyThe neuropeptides slowed inactivation and induced
and Zajac, 1998). In mammals, the nonopioid receptor(s)sustained currents during acidification. The effects
for FMRFamide and related peptides has not been iden-were specific; different channels showed distinct re-
tified, and it is not known how these peptides modulatesponses to the various peptides. These results sug-
pain sensation. However, the discovery of a FMRFamide-gest that acid-sensing ion channels may integrate
activated Na1 channel (FaNaCh) in the mollusc Helixmultiple extracellular signals to modify sensory per-
aspersa (Lingueglia et al., 1995) provided a clue thatception.
similar receptors might exist in mammals.
Unlike many neuropeptide receptors, FaNaCh is an ionIntroduction
channel gated directly by its peptide ligand, FMRFamide
(Lingueglia et al., 1995). The neuropeptide receptor
FMRFamide (Phe-Met-Arg-Phe amide) and related pep- FaNaCh is a member of the DEG/ENaC family of chan-
tides comprise a family of neuropeptides that are abun- nels. DEG/ENaC channels are homo- or heteromultimers
dant in many invertebrates, including Caenorhabditis composed of multiple subunits (Bassilana et al., 1997;
elegans (Nelson et al., 1998), Aplysia californica (Green- Lingueglia et al., 1997; Coscoy et al., 1998; Waldmann
berg and Price, 1992), and Drosophila melanogaster and Lazdunski, 1998). Each subunit contains two trans-
(Schneider and Taghert, 1988). In these organisms, membrane domains separated by a large, extracellular,
FMRFamide-like neuropeptides act as neurotransmit- cysteine-rich domain and cytosolic N and C termini (Wald-
ters and neuromodulators. At least one gene encoding mann and Lazdunski, 1998). DEG/ENaC channels are
FMRFamide-related peptides is present in mammals; it not voltage gated and are cation selective (usually Na1 .
produces neuropeptide FF (Phe-Leu-Phe-Gln-Pro-Gln- K1). FaNaCh is the only known DEG/ENaC channel that
Arg-Phe amide) and neuropeptide AF (A18Famide) (Perry acts as a neuropeptide receptor. Other members of this
et al., 1997; Vilim et al., 1999). Although FMRFamide family are involved in mechanosensation, salt taste, and
itself has not been discovered in mammals (Yang et al., epithelial Na1 absorption (Schild et al., 1995; Snyder et
1985), administration of FMRFamide induces a variety al., 1995; Lindemann, 1996; Mano and Driscoll, 1999).
of physiologic effects, including alterations in blood Although a mammalian FaNaCh has not yet been iso-
pressure, respiratory rate, glucose-stimulated insulin re- lated, mammals do possess multiple DEG/ENaC family
lease, and behavior (Mues et al., 1982; Sorenson et al., members. Interestingly, one subset of this channel fam-
1984; Kavaliers and Hirst, 1985; Raffa et al., 1986; Kava- ily, the acid-sensing ion channels, has been postulated
liers, 1987; Telegdy and BolloÂ k, 1987; Thiemermann et to play a role in sensory perception and may, like
al., 1991; Muthal et al., 1997; Nishimura et al., 2000). In FMRFamide, play a role in pain perception (Waldmann
mammals, FMRFamide and neuropeptide FF also mod- and Lazdunski, 1998). The acid-sensing DEG/ENaC
ify the response to painful stimuli, and neuropeptide FF channels respond to protons and generate a voltage-
is induced by inflammation (Tang et al., 1984; Yang et insensitive cation current when the extracellular solution
al., 1985; Raffa and Connelly, 1992; Kontinen et al., 1997; is acidified.
Vilim et al., 1999). When FMRFamide or neuropeptide The tissue acidosis associated with inflammation, in-
fection, and ischemia causes pain (Reeh and Steen,
1996). Acidosis also generates proton-dependent tran-§ To whom correspondence should be addressed (e-mail: mjwelsh@
blue.weeg.uiowa.edu). sient and sustained Na1 currents in cultured sensory
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neurons (Krishtal and Pidoplichko, 1981; Davies et al.,
1988; Akaike et al., 1990; Kovalchuk Yu et al., 1990;
Bevan and Yeats, 1991; Akaike and Ueno, 1994). Al-
though the molecular identity of the channels responsi-
ble for these currents is unknown, they have been hy-
pothesized to be acid-sensing members of the DEG/
ENaC protein family based on their ion selectivity, volt-
age insensitivity, and expression pattern (Bassilana et
al., 1997; Lingueglia et al., 1997; Waldmann et al., 1997a,
1997b; de Weille et al., 1998; Babinski et al., 1999). The
acid-sensing ion channels include the brain Na1 channel
1 (BNC1, also known as MDEG, BNaC1, and ASIC2) and
its differentially spliced isoform, MDEG2 (Price et al.,
1996; Waldmann et al., 1996; GarcõÂa-Anoveros et al.,
1997; Lingueglia et al., 1997); the acid-sensing ion chan-
nel (ASICa, also known as BNaC2 and ASIC1) and its
differentially spliced isoform, ASICb (Waldmann et al.,
1997b; Chen et al., 1998); and the dorsal root acid-
sensing ion channel (DRASIC, also known as ASIC3)
(Waldmann et al., 1997a; de Weille et al., 1998; Babinski
et al., 1999). BNC1, MDEG2, ASICa, and DRASIC are
expressed in the central nervous system (Lingueglia et
al., 1997; Waldmann et al., 1997b; Chen et al., 1998;
Olson et al., 1998). ASICa, ASICb, DRASIC, and MDEG2
are expressed in sensory neurons of the dorsal root
ganglia (DRG) (Waldmann et al., 1997a; Chen et al., 1998;
Olson et al., 1998; Babinski et al., 1999).
We hypothesized that FMRFamide or FMRFamide
Figure 1. Proton-Gated Currents in Rat DRG Neurons Are Modulated
like-neuropeptides might modulate pH-dependent cur- by FMRFamide
rents in DRG neurons. This hypothesis was based on the (A) Trace of proton-gated whole-cell current; FMRFamide (100 mM)
ability of FMRFamide and related peptides to modulate and pH 5 solution were present in bath during time indicated by bars.
pain perception, the potential connections between Unless otherwise indicated, pH was 7.4; n 5 8.
(B) Naloxone (100 mM) was present during time indicated by bar;painful stimuli and the acid-gated currents in DRG neu-
n 5 3.rons, and the sequence similarity between FaNaCh and
(C) Morphine (50 mM) and FMRFamide (50 mM) were added as indi-the acid-sensing ion channels expressed in sensory
cated; n 5 3.
ganglia. (D) Neuropeptide FF (NPFF) (50 mM) and FMRFamide (50 mM) were
present at times indicated by bar; n 5 5.
Results
FMRFamide Modulates Proton-Gated Current not mimic it (Figure 1C). These results suggested that
in Rat DRG Neurons FMRFamide was not acting through opioid receptors to
We used whole-cell patch-clamp recordings to investi- alter current.
gate the effect of FMRFamide on proton-gated currents We also tested the mammalian FMRFamide-like neu-
in cultured rat DRG neurons. As previously reported ropeptide FF. Neuropeptide FF modulated currents in a
(Krishtal and Pidoplichko, 1981; Akaike et al., 1990; Ko- manner similar to that of FMRFamide; it generated no
valchuk Yu et al., 1990; Akaike and Ueno, 1994), acidifi- current on its own, but it altered inactivation of proton-
cation to pH 5 produced rapidly activating and inactivat- gated DRG currents (Figure 1D). The effects, however,
ing currents in the sensory neurons (Figures 1A±1D). were smaller than those generated by FMRFamide (Fig-
FMRFamide added alone generated no response from ure 1D).
any of the neurons tested. However, after FMRFamide
addition (50±100 mM), the inactivation of proton-depen-
dent currents slowed, and in many neurons there was Effect of FMRFamide on Acid-Sensing Ion Channels
Members of the DEG/ENaC family are thought to be ata sustained current in the continued presence of acid
(Figures 1A and 1B). The presence of the neuropeptide least partially responsible for the acid-gated currents
in the DRG. This notion is based on the findings thatimmediately before acidification also altered inactiva-
tion (Figures 1C and 1D); we examine this further below. H1-gated currents from DRG and DEG/ENaC channels,
although not identical, share similar pH sensitivity, ionSome effects of FMRFamide are thought to be medi-
ated through activation of opiate receptors (Raffa, 1988; selectivity, and inactivation (Davies et al., 1988; Bevan
and Yeats, 1991; Bassilana et al., 1997; Lingueglia etRoumy and Zajac, 1998). To discern whether this might
account for potentiation of the proton-gated currents, al., 1997; Waldmann et al., 1997a, 1997b; de Weille et
al., 1998; Babinski et al., 1999). The differences may bewe tested the effect of naloxone, an opiate antagonist,
and morphine, an opiate agonist. Naloxone did not block due to as yet unidentified subunits and/or heteromulti-
meric complexes. Because FMRFamide affected DRGthe effect of FMRFamide (Figure 1B), and morphine did
FMRFamide Modulates Acid-Evoked Currents
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Figure 3. FMRFamide Modulates ASICa Function in Excised, Outside-
Out Patches
Tracing is representative of H1-dependent currents recorded from
HEK293T cells transfected with ASICa. FMRFamide (100 mM) and pH
5 solution were present in extracellular solution during time indicated
by bars; otherwise, pH was 7.4; n 5 6.
channels may be responsible, at least in part, for proton-
gated currents in neurons. For further studies, we fo-
cused on ASICa since it has been the most extensively
studied, it is localized in nociceptive neurons of the DRG
(Olson et al., 1998), and it produced a stable sustained
current with FMRFamide addition.
We also tested the effect of FMRFamide on ASICa
in excised, outside-out patches from HEK293T cells.Figure 2. Effect of FMRFamide on H1-Gated DEG/ENaC Family
Figure 3 shows that lowering the extracellular pH acti-Members
vated transient currents. In the presence of FMRFamide,Data are representative traces from Xenopus oocytes expressing
inactivation was slowed substantially. These data sug-ASICa (A), ASICb (B), DRASIC (C), or BNC1 (D); from water-injected
oocyte (E); or from HEK293T cells expressing ASICa (F). Unless other- gest that FMRFamide interacts with ASICa.
wise indicated, extracellular pH was 7.4. FMRFamide (50 or 100 mM)
and pH 5 solution were present in extracellular solution during time
Sequence of Adding FMRFamide and Acidificationindicated by bars. Experiments were repeated at least seven times.
In cells expressing ASICa, the presence of FMRFamide
before and during acidification induced a sustainedcurrents, we reasoned that FMRFamide might alter acid-
current (Figure 4Aiii). The continued presence ofgated DEG/ENaC channels. To test this hypothesis, we
FMRFamide did not prevent channel closure when pHexpressed mammalian acid-sensitive ion channels in
was returned to 7.4 (Figure 4Aiii). Thus, FMRFamide couldXenopus oocytes and measured the resulting currents.
neither activate nor sustain the current; rather, it modu-ASICa and its alternatively spliced variant, ASICb, gen-
lated acid-activated current. This stands in sharp contrasterated rapidly inactivating currents when the extracellu-
to FaNaCh, which opens in response to FMRFamidelar pH was lowered from 7.4 to 5 (Figures 2A and 2B).
alone and not acid (Lingueglia et al., 1995). The se-In contrast to its effect on FaNaCh, FMRFamide alone
quence of acid and FMRFamide application was impor-had no effect on either channel. However, subsequently
tant. The largest sustained currents required FMRFamidelowering pH in the presence of FMRFamide potentiated
addition before lowering the extracellular pH; simultane-the current; Figures 2A and 2B show slowing of inactiva-
ous addition of FMRFamide and acid (Figure 4Avi) ortion and the appearance of a sustained current at pH 5
addition of FMRFamide after acid (Figure 4Aiv) wasin both ASICa and ASICb. DRASIC showed a similar
much less effective. In contrast, when we first appliedresponse in the presence of FMRFamide (Figure 2C);
FMRFamide at pH 7.4 and then washed away thefollowing a reduction in pH, inactivation was slowed,
FMRFamide while simultaneously lowering pH, a sus-and a sustained current was more apparent. In contrast,
tained current still ensued (Figure 4Av). With ASICa ex-the acid-gated currents from oocytes expressing BNC1
pressed in HEK293T cells, the maximal sustained cur-were not discernibly altered by FMRFamide (Figure 2D).
rent also required addition of FMRFamide prior toNeither pH nor FMRFamide in any combination pro-
acidification (Figures 4Bii and 4Biii); application ofduced current in control, water-injected oocytes (Fig-
FMRFamide after the pH reduction failed to induce large,ure 2E).
sustained current (Figure 4Biv). Therefore, modulationFMRFamide also altered the function of ASICa ex-
required FMRFamide addition at pH 7.4, when the chan-pressed in the human cell line HEK293T (Figure 2F).
nel was closed.Acidic extracellular solutions induced rapidly inactivat-
It seemed surprising that FMRFamide could generateing whole-cell currents. In the presence of FMRFamide,
a sustained current, even when it was removed whileinactivation slowed, and a sustained current was appar-
the pH was being lowered (Figures 4Av and 4Biii). Weent. The effect of FMRFamide on current from acid-
observed similar behavior with acid-evoked currents ingated channels expressed in Xenopus oocytes and
DRG cells (Figures 1C and 1D). To investigate this fur-mammalian cells mimicked that observed in DRG neu-
rons. This similarity suggested that these DEG/ENaC ther, we examined the effect of removing FMRFamidefrom
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We asked whether FMRFamide alters the properties
of ASICa transient currents and whether the FMRFamide-
generated sustained current has properties different
from the transient current. Figures 5B and 5C show that
the FMRFamide-induced sustained current was inhib-
ited by amiloride in oocytes and HEK293 cells. Figure 5D
shows that FMRFamide did not alter the pH sensitivity of
the transient current. The FMRFamide-induced sus-
tained current, however, showed sensitivity to a broader
pH range compared with the transient current. This
broader range of sensitivity might allow a more graded
pH response of the FMRFamide-bound channel. This
may have implications for the perception of acid-evoked
pain, since sustained currents are thought to play a
role in pH-dependent nociception (Bevan and Geppetii,
1994).
The current±voltage (I±V) relationship of the H1-acti-
vated transient current of ASICa showed cation selectiv-
ity similar to what has been reported previously (Wald-
mann et al., 1997b); the relative permeabilities were Na1/
Li1 5 0.95 6 0.06 and Na1/K1 5 6.76 6 0.40. The slope
conductance was similar for all of the cations. The I±V
relationship of the peak current was not altered in the
presence of FMRFamide (Figure 5E). The sustained cur-
rent showed a somewhat different ion selectivity (Figure
5F); the relative permeability was Na1/Li1 5 1.05 6 0.07
and Na1/K1 5 1.25 6 0.2, and the slope conductivity
sequence was Na1 $ Li1 . K1. The sustained current
did not show Ca21 conductance. Thus, FMRFamide did
not alter the ASICa response to pH or the properties
of the initial transient current. However, the sustained
current showed a different cation selectivity and pH
Figure 4. Effect of Order of FMRFamide and Acid Addition response.
Data are whole-cell currents from Xenopus oocytes expressing ASICa
(A and C) (n 5 5 each) or HEK293T cells expressing ASICa (B) (n 5 Effect of FMRFamide-like Neuropeptides on ASICa
8). Roman numerals indicate specific interventions referred to in text.
Since FMRFamide itself has not been found in mammals,pH was 7.4, unless otherwise indicated. FMRFamide (50 or 100 mM)
we asked whether other FMRFamide-like peptides wouldand pH 5 solution were present in bath during times indicated by bars.
more potently affect ASICa. We tested FMRFamide-likeIn (C), cell was continuously perfused with solution, at pH 7.4 or pH
5, for 80 s during time indicated by box. compounds that have been identified in mammals, in-
cluding neuropeptide FF and A18Famide, which termi-
nate with the sequence PQRFamide (Yang et al., 1985;the bath solution at either pH 7.4 or pH 5. FMRFamide
Perry et al., 1997), and MERF (met-enkephalin-Arg-Phe),was applied at pH 7.4, and then the bath was continu-
which ends with FMRF but lacks the amide. Neitherously washed for 80 s (Figure 4Diii). After this time, acidi-
A18Famide nor MERF altered ASICa current, and neuro-fication generated no sustained current (Figure 4Div).
peptide FF produced only minor effects on inactivationThis result suggests that during the 80 s wash, the pep-
(Figure 6; see below). We tested several of the manytide dissociated or the effect reversed. However, when
neuropeptides terminating with RFamide that have beenthe pH was reduced while simultaneously removing
discovered in invertebrates (Schneider and Taghert,FMRFamide, the sustained current persisted throughout
1988; Greenberg and Price, 1992; Perry et al., 1997;an 80 s pH 5 wash and beyond (Figure 4Dv). These
Nelson et al., 1998). FLRFamide also induced a sus-results suggest that the effect of FMRFamide is only
tained current in ASICa, albeit less than did FMRFamidereversible at pH 7.4; once the channel has been acti-
(Figure 6). N-terminal extensions of FLRFamide andvated by acid, the effect of FMRFamide is retained until
other RFamide-containing peptides identified in inverte-the pH is returned to 7.4.
brates did not alter ASICa currents in the presence (Fig-
ure 6) or absence of acid. FMRF-OH did not induce aProperties of the Current Generated by pH
response, indicating that the C-terminal amide is re-and FMRFamide
quired. These results are similar to the neuropeptideFMRFamide concentrations around 1 mM induced de-
specificity observed for FaNaCh, which has been re-tectable sustained currents in cells expressing ASICa
ported to respond only to FMRFamide and FLRFamide(Figure 5A). Maximal levels of sustained current were
(Cottrell, 1997). We tested morphine to determineachieved at z250 mM FMRFamide. The FMRFamide
whether it could induce a sustained current and nalox-concentration that induced half-maximal sustained cur-
one to see if it blocked FMRFamide-induced sustainedrents was z33 mM. This concentration is higher than
that reported for FaNaCh (2 mM) (Lingueglia et al., 1995). current in Xenopus oocytes. Consistent with our results
FMRFamide Modulates Acid-Evoked Currents
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Figure 5. Properties of FMRFamide-Modu-
lated ASICa Current
Data are from Xenopus oocytes (A, B, and D±F)
or HEK293T cells (C) expressing ASICa.
(A) Effect of FMRFamide concentration on po-
tentiation of H1-dependent sustained current.
Oocytes were exposed to indicated concentra-
tions of FMRFamide prior to and during current
activation with pH 5 solution. Measurements
were normalized to the value of sustained cur-
rent obtained with 500 mM FMRFamide. Data
are mean 6 SEM; n 5 6±7.
(B) Effect of amiloride on FMRFamide and acid-
induced sustained current. Amiloride (1 mM),
FMRFamide (50 mM), and pH 5 are indicated
by bars; n 5 5.
(C) Amiloride (100 mM), FMRFamide (100 mM),
and pH 5 are indicated by bars; n 5 3.
(D) pH sensitivity of ASICa current with addition
of FMRFamide. FMRFamide (50 mM) was
added prior to acidification. Values were nor-
malized to current obtained at pH 3 for the
transient and the FMRFamide-modulated sus-
tained current. Data are mean 6 SEM; n 5 7.
(E and F) I±V relationships of ASICa current
measured at pH 5 in the presence and absence
of FMRFamide (50 mM); extracellular bath solu-
tion containing 116 mM Na1, K1, or Li1, as
indicated. In these studies, the solution was
changed from 116 mM Na1 to the other cations
z30 s before acidification, and membrane volt-
age was stepped from a holding voltage of
260 mV to voltages of 280, 210, or 160 mV
immediately before acidification. Currents from
each cell were normalized to current obtained
in the same cell at 280 mV in the Na1 solution
(100%) (E) or the sustained currents (F). Data
are mean 6 SEM; n 5 8 cells for Na1 solution
and 4 cells for K1 and Li1 solutions.
in rat DRG (Figures 1B and 1C), neither morphine nor a pronounced specificity difference between acid-gated
channels. With ASICa, equivalent concentrations ofnaloxone altered ASICa current (Figure 6).
FRRFamide generated a sustained current similar to that
produced by FMRFamide, although it was smaller inDifferential Effects of FMRFamide and FRRFamide
In an attempt to learn more about the peptide specificity magnitude (Figure 7A). With ASICb, FRRFamide mark-
edly slowed the rate of inactivation without generatingof acid-gated channel modulation, we tested several
FXRFamide peptides. One of these, FRRFamide, showed as large a sustained current as FMRFamide (Figure 7B).
With DRASIC, both FRRFamide and FMRFamide slowed
inactivation of the transient current and increased the
sustained current, although equivalent concentrations
of FRRFamide had larger effect on transient and sus-
tained currents (Figure 7C).
Neuropeptide FF Potentiates DRASIC Current
Differential modulation of the various acid-sensing ion
channels by different peptides, and our finding that neu-
ropeptide FF modulated DRG currents, suggested that
we should test this mammalian neuropeptide on all of
the acid-sensing channels. Figure 8A shows that adding
neuropeptide FF prior to acidification slowed the inacti-
Figure 6. Effect of FMRFamide-like Peptides on ASICa Current vation of H1-gated DRASIC currents. Interestingly, the
Oocytes expressing ASICa were exposed to indicated peptides, mor- kinetics of neuropeptide FF±induced potentiation were
phine sulphate, or naloxone prior to and during acidification to pH 5. different from those induced by FMRFamide. Neuropep-
All agents were tested at 50 mM and normalized to the response to tide FF had subtle effects on ASICa currents, slowing
FMRFamide (50 mM) obtained in the same cell, except for A18Famide
inactivation but not generating appreciable sustained(25 mM) and naloxone (500 mM). Naloxone was applied before the
current (Figure 8B). ASICb and BNC1 appeared unaf-addition of FMRFamide. Data are mean 6 SEM for five to eight cells
assayed for each condition. fected by neuropeptide FF addition (data not shown).
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Figure 7. Effect of FMRFamide and FRRFamide on H1-Gated DEG/
ENaC Family Members Expressed in Xenopus Oocytes
(A and B) ASICa and ASICb. FMRFamide (50 mM), FRRFamide (50
mM), and pH 5 solution were present in extracellular solution during Figure 8. Effect of Neuropeptide FF on DRASIC and ASICa Expressed
time indicated by bars; n 5 at least 8. in Xenopus Oocytes
(C) DRASIC. FMRFamide (100 mM), FRRFamide (100 mM), and pH 4
Neuropeptide FF (NPFF) (50 mM) and FMRFamide (50 mM) were presentsolution were present as indicated by bars; n 5 6.
at times indicated by bars; n 5 5.
Payza and Yang, 1993; Gherardi and Zajac, 1997; Nishi-Discussion
mura et al., 2000). Our data indicate that mammalian
members of the DEG/ENaC channel family also respondOur data indicate that FMRFamide-related neuropep-
to FMRFamide-like peptides. There are at least threetides potentiate currents from acid-sensing DEG/ENaC
possible explanations. FMRFamide-related peptideschannels. Moreover, the localization of acid-sensing ion
might bind directly to acid-sensing channels, analogouschannels and FMRFamide-like peptides suggest the two
to their interaction with FaNaCh. FMRFamide-relatedmay interact in vivo. Both DRASIC and neuropeptide FF
peptides might bind a receptor that triggers intracellularare found in the DRG (Waldmann et al., 1997a; Chen et
second messengers that modify the acid-sensing ional., 1998; Allard et al., 1999). They are also both localized
channels. Finally, FMRFamide-related peptides mightin the spinal cord and brain (Majane and Yang, 1987;
bind a protein associated with acid-sensing ion chan-Majane et al., 1989; Chen et al., 1998). Moreover,
nels, thereby altering their function. We favor the possi-FMRFamide immunoreactivity that does not appear to
bility of a direct interaction for the following reasons.be neuropeptide FF is found in DRG and brain (Ferrarese
First, the effect of FMRFamide was not mimicked byet al., 1986; Majane and Yang, 1987; Vilim et al., 1999).
morphine or blocked by naloxone. Second, FMRFamideIn this regard, it is interesting that FMRFamide was more
had the same effect on ASICa expressed in widely diver-potent than was neuropeptide FF in activating ASIC and
gent cell types, Xenopus oocytes, and a human cell line.DRG currents. We speculate that additional FMRFamide-
If the effect of FMRFamide were indirect, both cell typesrelated peptides await discovery.
would have to express similar endogenous receptors
coupled to similar second messenger systems. Third,
in cells expressing the various individual acid-gatedPotentiation of Acid-Gated Currents
by FMRFamide-Related Peptides channels, FMRFamide, FRRFamide, and neuropeptide
FF generated currents that were not only quantitativelyEarlier studies suggest that FMRFamide-like peptides
can activate multiple types of receptors in mammals. different, but also, more importantly, qualitatively differ-
ent. If these neuropeptides had different affinities for anThese may include an opioid receptor, a G protein±
coupled receptor that activates second messenger unidentified endogenous receptor coupled to a second
messenger, then only quantitative differences would bepathways, and other receptors that so far have remained
unidentified (Kavaliers, 1987; Raffa and Connelly, 1992; expected. Moreover, such a scenario would predict that
FMRFamide Modulates Acid-Evoked Currents
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the quantitative effects would be similar for the different in nociception. Interestingly, these peptides have been
previously linked to pain perception in the spinal cordchannels. This was not the case. Fourth, application of
FMRFamide altered ASICa function in excised, outside- and brain. For example, chronic inflammation induces
neuropeptide FF expression in the spinal cord (Kontinenout patches of membrane. Experiments to unambiguously
determine whether the effect of FMRFamide-related pep- et al., 1997; Vilim et al., 1999). FMRFamide-related pep-
tides may also contribute to opiate tolerance, in whichtides is direct or indirect will require additional work.
The discovery that FMRFamide activated the mol- increasing amounts of opiates are required to achieve
the same analgesic effect (Raffa, 1988; Roumy and Za-luscan FaNaCh showed that a peptide neurotransmitter
could directly gate an ion channel (Lingueglia et al., jac, 1998). This may in part be explained by opiate-
induced secretion of FMRFamide-related peptides from1995). Our data suggest that the same peptide interacts
with the evolutionarily related ASIC and DRASIC chan- spinal cord neurons possibly inducing hypersensitivity
of the nociceptive neurons (Tang et al., 1984).nels. However, FMRFamide did not open these mamma-
lian channels on its own; rather, it modulated the re- Our data may also have implications for DEG/ENaC
function in the brain. For example, intracerebroventricu-sponse to another agonist, protons. If FMRFamide
interacts directly with the channels, these findings sug- lar injection of FMRFamide-related peptides induces a
variety of physiologic responses (Mues et al., 1982; Sor-gest that a FMRFamide-binding site has been at least
partly conserved in these DEG/ENaC channels but that enson et al., 1984; Tang et al., 1984; Kavaliers and Hirst,
1985; Yang et al., 1985; Raffa et al., 1986; Kavaliers,changes in structure have altered the consequences of
the interaction. The alternatively spliced isoforms, ASICa 1987; Thiemermann et al., 1991; Raffa and Connelly,
1992; Muthal et al., 1997; Roumy and Zajac, 1998). Re-and ASICb, are identical over most of their length; how-
ever, the amino acid sequence from their N termini, cently, it was demonstrated that an amiloride analog
inhibits FMRFamide-induced regulation of the brain re-through M1, and for a short distance (z100 amino acids)
into the extracellular domain is not the same. Differences nin±angiotensin system and hypertension (Nishimura et
al., 2000). This suggests that these channels are a targetin the responses of ASICa and ASICb to FMRFamide
and FRRFamide suggest that the more N-terminal por- of FMRFamide in the brain.
Proton-gated DEG/ENaC channels may function totions of ASIC contribute to neuropeptide modulation.
That, plus the distinct interactions of FMRFamide and integrate the response to acid and neuropeptides in the
nervous system. Interestingly, another channel thoughtneuropeptide FF with FaNaCh and DRASIC, and the lack
of a response with BNC1, provide a strategy and the to be involved in nociception, the capsaicin receptor,
also integrates multiple stimuli, heat and acidosis (Cat-reagents to investigate where and how these channels
interact with FMRFamide and related peptides. erina et al., 1997; Tominaga et al., 1998). Thus, in neu-
rons H1-gated currents could vary, depending upon theIt is intriguing that FMRFamide should be applied be-
fore acid. We propose the following model. At pH 7.4, type and combinations of DEG/ENaC subunits ex-
pressed and on the presence of different FMRFamide-FMRFamide binds and is free to dissociate. However,
when FMRFamide is bound at pH 7.4 and then pH is like neuropeptides. The diversity of channel subunits
and neuropeptides offers rich opportunities for interac-lowered, FMRFamide becomes trapped in the binding
site. When the binding site is unoccupied, the channel in- tions and new targets for pharmacotherapy.
activates rapidly, even in the continued presence of acid.
However, when the binding site contains FMRFamide,
Experimental Procedures
channel inactivation is slowed and/or partially pre-
vented. This scenario would explain two other observa- cDNA Constructs
tions. The limited ability of the peptide to alter current Human ASICa was cloned from brain poly(A) RNA. Rat ASICb and
mouse DRASIC were cloned from DRG RNA. Human BNC1 waswhen applied after acidification could be explained by
cloned as described (Price et al., 1996). Constructs were cloneda conformational change at a low pH that occludes or
into pMT3 for expression. The validity of the constructs was con-hides the FMRFamide-binding site (Figures 4A and 4B).
firmed by DNA sequencing.
Trapping of FMRFamide within an occluded binding site
at low pH would explain the continued generation of
Cells and Expression Systemssustained currents, even after the peptide was removed
Rat DRG neurons were cultured from Norway rats as describedfrom the bath (Figure 4D). This interpretation is consis-
(Benson et al., 1999). Cells were allowed to incubate overnight at
tent with our earlier observation that acid pH causes a room temperature, and studies were done 1±2 days after isolation.
conformational change in the related BNC1 channel that Expression of the cDNA constructs in Xenopus oocytes was ac-
complished by injection of plasmid DNA into the nucleus of defollicu-altered the extracellular solvent accessibility of a spe-
lated albino Xenopus laevis oocytes (Nasco, Fort Atkinson, WI) ascific residue (Adams et al., 1998).
described previously (Adams et al., 1998). Plasmids were injected
at concentrations of 100 ng/ml for most experiments. Oocytes were
Physiologic Implications incubated in modified Barth's solution at 188C for 12±26 hr after
It has been suggested that tissue ischemia and inflam- injection. Cells injected with DRASIC were allowed to incubate for
24±48 hr before analysis.mation cause pain by stimulating H1-gated cation cur-
HEK293T cells were a gift of Dr. Mark Stinski (University of Iowa).rents (Reeh and Steen, 1996). The sustained component
ASICa cDNA was transfected into HEK293T cells using Transfastof those currents is thought to be particularly important
lipid reagents (Promega, Madison, WI). To identify transfected cells,(Bevan and Yeats, 1991; Lingueglia et al., 1997). Thus,
pGreenlantern vector encoding green fluorescent protein (GIBCO,
the ability of neuropeptide FF and FMRFamide-related Gaithersburg, MD) was cotransfected with ASICa at a ratio of 1:6;
peptides to induce sustained currents suggests that transfected cells were identified using epifluorescence microscopy.
Cells were studied 1±2 days after transfection.such peptides and the acid-gated channels play a role
Neuron
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Electrophysiological Analysis Bevan, S., and Yeats, J. (1991). Protons activate a cation conduc-
tance in a sub-population of rat dorsal root ganglion neurones. J.Whole-cell currents in oocytes were measured using two-electrode
Physiol. (Lond) 433, 145±161.voltage-clamp as described previously (Adams et al., 1998). Oocytes
were bathed in frog Ringer solution containing, in mM: NaCl, LiCl, Brussaard, A.B., Kits, K.S., Ter Maat, A., Mulder, A.H., and Schoffel-
or KCl, 116; CaCl2, 0.4; MgCl2, 1; and 4-(2-hydroxyethyl)-1-pipera- meer, A.N.M. (1989). Peripheral injection of DNA-RFa, a FMRFa ago-
zineethanesulfonic acid (HEPES), 5 (pH 7.4). Acidic solutions were nist, suppresses morphine-induced analgesia in rats. Peptides 10,
buffered with 5 mM 2-(4-morpholino)-ethanesulfonic acid (MES) in- 735±739.
stead of HEPES. Membrane voltage was held at 260 mV, unless Caterina, M.J., Schumacher, M.A., Tominaga, M., Rosen, T.A., Le-
otherwise noted. Most peptides and naloxone were obtained from vine, J.D., and Juluis, D. (1997). The capasaicin receptor: a heat-
Sigma (St. Louis, MO) and were added to the extracellular solution. activated ion channel in the pain pathway. Nature 389, 816±824.
The peptide FRRFamide was synthesized by Research Genetics
Chen, C.-C., England, S., Akopian, A.N., and Wood, J.N. (1998). A(Huntsville, AL).
sensory neuron±specific, proton-gated ion channel. Proc. Natl.During whole-cell patch clamping of DRG neurons and transfected
Acad. Sci. USA 95, 10240±10245.
HEK293T cells, the cells were bathed with an extracellular solution
Coscoy, S., Lingueglia, E., Lazdunski, M., and Barbry, P. (1998). Thethat contained, in mM: NaCl, 128; MgCl2, 5; CaCl2, 1.8; KCl, 5.4;
Phe-Met-Arg-Phe-amide-activated sodium channel is a tetramer. J.glucose, 5.55; and HEPES, 20 (pH 7.5 or 5). The pipette solution
Biol. Chem. 273, 8317±8322.contained, in mM: KCl, 120; NaCl, 10; MgCl2, 2; EGTA, 5; and HEPES,
Cottrell, G.A. (1997). The first peptide-gated ion channel. J. Exp.10. Perfusion of cells with different solutions was done by placing
Biol. 200, 2377±2386.the appropriate outlet in front of the cell. Data were recorded with
an Axopatch 200 (Axon Instruments, Foster City, California) and Davies, N.W., Lux, H.D., and Morad, M. (1988). Site and mechanism
stored on a digital tape recorder. Digitization was executed by ac- of activation of proton-induced sodium current in chick dorsal root
quiring data at 400 Hz using pClamp6 (Axon Instruments). ganglion neurones. J. Physiol. (Lond) 400, 159±187.
Excised, outside-out patches were obtained from transfected Devillers, J.P., Boisserie, F., Laulin, J.P., Larcher, A., and Simonnet,
HEK293T cells. The bath solution contained, in mM: NaCl, 140; G. (1995). Simultaneous activation of spinal antiopioid system (neu-
MgCl2, 2; CaCl2, 1.8; HEPES, 10 (pH 7.4), or Tris(hydroxymethyl)ami- ropeptide FF) and pain facilitatory circuitry by stimulation of opioid
nomethane (Tris) or MES (pH 5). The pipette solution contained, in receptors in rats. Brain Res. 700, 173±181.
mM: NMDG±Cl, 140; MgCl2, 2; EGTA, 2; and HEPES, 10 (pH 7.4). de Weille, J.R., Bassilana, F., Lazdunski, M., and Waldmann, R.
(1998). Identification, functional expression and chromosomal local-
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